. Gametogenesis-research, U. Center, I. , and A. U1086, Interdisciplinary Research for Cancers prevention and treatment, axis BioTICLA (Biology and Innovative Therapeutics for Ovarian Cancer), Research Center for Biochemistry and Nutrition in Metabolic Diseases

, Reference

J. Ferlay, cancer incidence and mortality worldwide: IARC CancerBase No. 10, Lyon: International Agency for Research on Cancer, p.29, 2008.

J. Kalsi, R. Manchanda, and U. Menon, Screening for gynecological cancers, Expert Review of Obstetrics & Gynecology, vol.286, issue.2, pp.143-60, 2013.
DOI : 10.1007/s00404-012-2492-2
URL : https://qmro.qmul.ac.uk/xmlui/bitstream/123456789/13602/1/Manchanda%20Screening%20for%20gynecological%202014%20Accepted.pdf

A. Hildesheim, Sexually transmitted agents and risk of carcinoma of the vagina, International Journal of Gynecological Cancer, vol.7, issue.4, pp.251-256, 1997.
DOI : 10.1046/j.1525-1438.1997.00462.x

V. Shilpa, Molecular Profiling of Gynaecologic Malignancies: A Review. Hereditary Genetics: Current Research, pp.1-9, 2016.

E. Dunne, CDC grand rounds: reducing the burden of HPV-associated cancer and disease, MMWR Morb Mortal Wkly Rep, vol.63, issue.4, pp.69-72, 2014.

A. Heintz, Carcinoma of the Fallopian Tube, International Journal of Gynecology & Obstetrics, vol.95, pp.145-60, 2006.
DOI : 10.1016/S0020-7292(06)60032-5

F. Medeiros, The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome, The American Journal of Surgical Pathology, vol.30, issue.2, pp.230-236, 2006.
DOI : 10.1097/01.pas.0000180854.28831.77

R. Kurman and I. Shih, The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory, The American Journal of Surgical Pathology, vol.34, issue.3, p.433, 2010.
DOI : 10.1097/PAS.0b013e3181cf3d79

D. Cavanagh, Adenocarcinoma of the Endometrium: An Institutional Review, Cancer Control, vol.22, issue.4, pp.354-60, 1999.
DOI : 10.1016/0029-7844(95)00001-8

H. Kitchener, Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study, Lancet, vol.373, issue.9658, pp.125-161, 2009.

I. Frazer, Prevention of cervical cancer through papillomavirus vaccination, Nature Reviews Immunology, vol.3, issue.Suppl. 1, pp.46-55, 2004.
DOI : 10.1007/s00432-003-0463-5

F. Kokka, Surgical treatment of stage IA2 cervical cancer, Cochrane Database of Systematic Reviews, vol.127, issue.1, 2014.
DOI : 10.1016/j.ygyno.2012.06.031
URL : https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010870.pub2/media/CDSR/CD010870/CD010870.pdf

D. Eddy, Screening for Cervical Cancer, Annals of Internal Medicine, vol.113, issue.3, pp.214-240, 1990.
DOI : 10.7326/0003-4819-113-3-214

L. Peirson, Screening for cervical cancer: a systematic review and meta-analysis. Systematic reviews, p.1, 2013.

R. Siegel, K. Miller, and A. Jemal, Cancer statistics, 2016, CA: A Cancer Journal for Clinicians, vol.61, issue.suppl 3, pp.7-30, 2016.
DOI : 10.3322/caac.20134

A. Jemal, Cancer Statistics, 2010, CA: A Cancer Journal for Clinicians, vol.60, issue.5, pp.277-300, 2010.
DOI : 10.3322/caac.20073

L. Huang, Improved survival time: What can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?, Cancer, vol.350, issue.10, pp.2289-300, 2008.
DOI : 10.1056/NEJMoa032709
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.23425

T. Kaku, Histological classification of ovarian cancer, Medical Electron Microscopy, vol.36, issue.1, pp.9-17, 2003.
DOI : 10.1007/s007950300002

U. Force, Screening for ovarian cancer: recommendation statement. The Annals of Family Medicine, pp.260-262, 2004.

A. Khalil, Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression, Proceedings of the National Academy of Sciences, vol.106, issue.28, pp.11667-72, 2009.
DOI : 10.1101/gr.6036807
URL : http://www.pnas.org/content/106/28/11667.full.pdf

J. Wilusz, H. Sunwoo, and D. Spector, Long noncoding RNAs: functional surprises from the RNA world, Genes & Development, vol.23, issue.13, pp.1494-504, 2009.
DOI : 10.1101/gad.1800909
URL : http://genesdev.cshlp.org/content/23/13/1494.full.pdf

M. Guttman, Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals, Nature, vol.322, issue.7235, pp.223-230, 2009.
DOI : 10.1093/bioinformatics/18.suppl_1.S136
URL : http://europepmc.org/articles/pmc2754849?pdf=render

J. Mattick, The Genetic Signatures of Noncoding RNAs, PLoS Genetics, vol.443, issue.4, p.1000459, 2009.
DOI : 10.1371/journal.pgen.1000459.t002
URL : https://doi.org/10.1371/journal.pgen.1000459

R. Carthew and E. Sontheimer, Origins and Mechanisms of miRNAs and siRNAs, Cell, vol.136, issue.4, pp.642-55, 2009.
DOI : 10.1016/j.cell.2009.01.035
URL : https://doi.org/10.1016/j.cell.2009.01.035

G. Borchert, W. Lanier, and B. Davidson, RNA polymerase III transcribes human microRNAs, Nature Structural & Molecular Biology, vol.13, issue.12, pp.1097-101, 2006.
DOI : 10.1038/nsmb1141

J. Prensner and A. Chinnaiyan, The Emergence of lncRNAs in Cancer Biology, Cancer Discovery, vol.1, issue.5, pp.391-407, 2011.
DOI : 10.1158/2159-8290.CD-11-0209

R. Gupta, Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis, Nature, vol.38, issue.7291, pp.1071-1077, 2010.
DOI : 10.1038/nrc2089
URL : http://europepmc.org/articles/pmc3049919?pdf=render

J. Qiu, Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer, Gynecologic Oncology, vol.134, issue.1, pp.121-129, 2014.
DOI : 10.1016/j.ygyno.2014.03.556

L. Huang, Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer, Archives of Gynecology and Obstetrics, vol.282, issue.31, pp.717-740, 2014.
DOI : 10.1074/jbc.M610724200

X. He, The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis, International Journal of Molecular Medicine, vol.33, issue.2, pp.325-357, 2014.
DOI : 10.3892/ijmm.2013.1570

R. Kogo, Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers, Cancer Research, vol.71, issue.20, pp.6320-6326, 2011.
DOI : 10.1158/0008-5472.CAN-11-1021
URL : http://cancerres.aacrjournals.org/content/canres/71/20/6320.full.pdf

Z. Yang, Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation, Annals of Surgical Oncology, vol.15, issue.5, pp.1243-50, 2011.
DOI : 10.1097/MOT.0b013e328339837b

T. Niinuma, Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors, Cancer Research, vol.72, issue.5, pp.1126-1162, 2012.
DOI : 10.1158/0008-5472.CAN-11-1803
URL : http://cancerres.aacrjournals.org/content/canres/72/5/1126.full.pdf

X. Sheng, Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer, Oncology Reports, vol.32, issue.1, pp.277-85, 2014.
DOI : 10.3892/or.2014.3208

X. Zhang, A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.11, pp.5119-5145, 2003.
DOI : 10.1210/jc.2003-030222
URL : https://academic.oup.com/jcem/article-pdf/88/11/5119/9059215/jcem5119.pdf

C. Braconi, microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer, Oncogene, vol.51, issue.47, pp.4750-4756, 2011.
DOI : 10.1074/jbc.M702029200

P. Wang, Z. Ren, and P. Sun, Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation, Journal of Cellular Biochemistry, vol.282, issue.47, pp.1868-74, 2012.
DOI : 10.1074/jbc.M702029200

J. Evans, F. Feng, and A. Chinnaiyan, The bright side of dark matter: lncRNAs in cancer, Journal of Clinical Investigation, vol.126, issue.8, p.2775, 2016.
DOI : 10.1172/JCI84421

S. Sharma, T. Kelly, and P. Jones, Epigenetics in cancer, Carcinogenesis, vol.8, issue.6, pp.27-36, 2010.
DOI : 10.1158/1535-7163.MCT-09-0013

M. Esteller, Epigenetics in Cancer, New England Journal of Medicine, vol.358, issue.11, pp.1148-59, 2008.
DOI : 10.1056/NEJMra072067

J. Lee, Epigenetic Regulation by Long Noncoding RNAs, Science, vol.363, issue.2, pp.1435-1444, 2012.
DOI : 10.1056/NEJMra0905980

Y. Schwartz and V. Pirrotta, A new world of Polycombs: unexpected partnerships and emerging functions, Nature Reviews Genetics, vol.17, issue.12, pp.853-64, 2013.
DOI : 10.1038/nrg1981

C. Kleer, EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells, Proceedings of the National Academy of Sciences, vol.6, issue.10, pp.11606-11617, 2003.
DOI : 10.1016/S0092-8674(00)81683-9

S. Varambally, The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, vol.277, issue.6907, pp.624-633, 2002.
DOI : 10.1074/jbc.M107795200

X. Hu, A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer, Cancer Cell, vol.26, issue.3, pp.344-57, 2014.
DOI : 10.1016/j.ccr.2014.07.009

C. Davidovich, Promiscuous RNA binding by Polycomb repressive complex 2, Nature Structural & Molecular Biology, vol.57, issue.11, pp.1250-1257, 2013.
DOI : 10.1093/nar/gkm226

J. Rinn, Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs, Cell, vol.129, issue.7, pp.1311-1334, 2007.
DOI : 10.1016/j.cell.2007.05.022

T. Mondal, MEG3 long noncoding RNA regulates the TGF-?? pathway genes through formation of RNA???DNA triplex structures, Nature Communications, vol.19, issue.1, pp.7743-60, 2015.
DOI : 10.1006/meth.1999.0879

C. Davidovich, Toward a Consensus on the Binding Specificity and Promiscuity of PRC2 for RNA, Molecular Cell, vol.57, issue.3, pp.552-560, 2015.
DOI : 10.1016/j.molcel.2014.12.017

Z. Li and T. Rana, Decoding the noncoding: Prospective of lncRNA-mediated innate immune regulation, RNA Biology, vol.152, issue.8, pp.979-85, 2014.
DOI : 10.1016/j.molcel.2013.07.017

D. Pereira, Delivering the promise of miRNA cancer therapeutics, Drug Discovery Today, vol.18, issue.5-6, pp.282-291, 2013.
DOI : 10.1016/j.drudis.2012.10.002

J. Mccaskill, RNA-mediated degradation of microRNAs: A widespread viral strategy?, RNA Biology, vol.160, issue.6, pp.579-85, 2015.
DOI : 10.1073/pnas.1408037111

C. Vennin, <i>H19</i> non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b, Oncotarget, vol.6, issue.30, pp.29209-29232, 2015.
DOI : 10.18632/oncotarget.4976

Y. Wu, Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease, Current Pharmaceutical Design, vol.21, issue.34, pp.5017-5045, 2015.
DOI : 10.2174/1381612821666150724115625

R. Yoshimoto, MALAT1 long non-coding RNA in cancer, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1859, issue.1, pp.192-201, 2016.
DOI : 10.1016/j.bbagrm.2015.09.012

P. Ji, MALAT-1, a novel noncoding RNA and thymosin ??4 predict metastasis and survival in early-stage non-small cell lung cancer, Oncogene, vol.22, issue.39, pp.8031-8072, 2003.
DOI : 10.1074/jbc.274.19.13698

R. Lin, Control of RNA processing by a large non-coding RNA over-expressed in carcinomas, FEBS Letters, vol.24, issue.4, pp.671-677, 2011.
DOI : 10.1016/j.molcel.2010.08.011

T. Gutschner, M. Hämmerle, and S. Diederichs, MALAT1 ??? a paradigm for long noncoding RNA function in cancer, Journal of Molecular Medicine, vol.157, issue.2, pp.791-801, 2013.
DOI : 10.1016/S0002-9440(10)64594-4

Q. Li, Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma, Cancer Letters, vol.383, issue.1, pp.28-40, 2016.
DOI : 10.1016/j.canlet.2016.09.019

Y. Zhao, A Novel Wnt Regulatory Axis in Endometrioid Endometrial Cancer, Cancer Research, vol.74, issue.18, pp.5103-5120, 2014.
DOI : 10.1158/0008-5472.CAN-14-0427
URL : http://cancerres.aacrjournals.org/content/canres/74/18/5103.full.pdf

J. Ying, Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation, Oncogene, vol.25, issue.7, pp.1070-80, 2006.
DOI : 10.1038/ng1521
URL : http://www.nature.com/onc/journal/v25/n7/pdf/1209154a.pdf

X. Zhong, Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer, Journal of Cancer Research and Clinical Oncology, vol.26, issue.7, pp.485-90, 2013.
DOI : 10.1093/carcin/bgi069

G. Narayan, Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer, Genes, Chromosomes and Cancer, vol.2, issue.11, pp.983-92, 2009.
DOI : 10.1016/S0002-9378(03)00418-6

M. Lai, Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation, Medical Oncology, vol.15, issue.3
DOI : 10.1093/molehr/gap071

, Med Oncol, vol.29, issue.3, pp.1810-1816, 2012.

I. F?ri, Cell Free DNA of Tumor Origin Induces a 'Metastatic'Expression Profile in HT-29 Cancer Cell Line, PLoS One, vol.10, issue.7, p.131699, 2015.

X. Wu, MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway, Cancer Biology & Therapy, vol.124, issue.6, pp.806-820, 2014.
DOI : 10.1002/jcp.23065

S. Liu, MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1, PLOS ONE, vol.13, issue.35, p.163460, 2016.
DOI : 10.1371/journal.pone.0163460.s001

L. Yang, High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion, Eur Rev Med Pharmacol Sci, vol.19, issue.17, pp.3187-93, 2015.

Y. Zhang, Human MALAT-1 long non-coding RNA is overexpressed in cervical cancer metastasis and promotes cell proliferation, invasion and migration, Journal of BU ON: official journal of the Balkan Union of Oncology, vol.20, issue.6, p.1497, 2015.

F. Guo, Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion, Acta Biochimica et Biophysica Sinica, vol.387, issue.6635, pp.224-233, 2010.
DOI : 10.1038/42867

S. Liu, Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials, Cancer biology & medicine, vol.10, issue.3, pp.138-179, 2013.

S. Liu, Inhibition of the long non-coding RNA MALAT1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer SKOV3 cell line, Oncology Letters, vol.11, issue.6, pp.3686-92, 2016.
DOI : 10.3892/ol.2016.4435

T. Hung and H. Chang, Long noncoding RNA in genome regulation, RNA Biology, vol.3, issue.5, pp.582-587, 2010.
DOI : 10.1038/ng1097-236

Y. Nie, is an independent prognostic marker for nasopharyngeal carcinoma progression and survival, Cancer Science, vol.72, issue.Suppl. 1, pp.458-64, 2013.
DOI : 10.1158/0008-5472.CAN-11-1803

A. Bhan, Antisense Transcript Long Noncoding RNA (lncRNA) HOTAIR is Transcriptionally Induced by Estradiol, Journal of Molecular Biology, vol.425, issue.19, pp.3707-3729, 2013.
DOI : 10.1016/j.jmb.2013.01.022

J. Huang, Lentivirus-Mediated RNA Interference Targeting the Long Noncoding RNA HOTAIR Inhibits Proliferation and Invasion of Endometrial Carcinoma Cells In Vitro and In Vivo, International Journal of Gynecological Cancer, vol.24, issue.4, pp.635-677, 2014.
DOI : 10.1097/IGC.0000000000000121

M. Hajjari and A. Salavaty, HOTAIR: an oncogenic long non-coding RNA in different cancers Cancer biology & medicine, pp.1-9, 2015.

J. Qiu, The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis, Experimental Cell Research, vol.333, issue.2, pp.238-286, 2015.
DOI : 10.1016/j.yexcr.2015.03.005

J. Li, Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/??-catenin pathway in human ovarian cancer, Tumor Biology, vol.9, issue.2, pp.2057-65, 2016.
DOI : 10.1371/journal.pone.0096577

H. Kim, Long non-coding RNA HOTAIR is associated with human cervical cancer progression, International Journal of Oncology, vol.46, issue.2, pp.521-551, 2015.
DOI : 10.3892/ijo.2014.2758

H. Kim, Long noncoding RNA HOTAIR is associated with human cervical cancer progression, Gynecologic Oncology, vol.133, p.5, 2014.
DOI : 10.1016/j.ygyno.2014.03.027

G. Smits, Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians, Nature Genetics, vol.212, issue.8, pp.971-977, 2008.
DOI : 10.1016/j.bbrc.2006.10.105

W. Jing, The Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-Analysis, BioMed Research International, vol.63, issue.8, 2016.
DOI : 10.1007/s13277-015-3779-2

E. Raveh, The H19 Long non-coding RNA in cancer initiation, progression and metastasis ??? a proposed unifying theory, Molecular Cancer, vol.108, issue.40, p.1, 2015.
DOI : 10.1073/pnas.1110904108

M. Ivanga, Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus, Physiological Genomics, vol.29, issue.1, pp.13-23, 2007.
DOI : 10.1016/S0163-7258(02)00199-7

S. Ayesh, Possible physiological role of H19 RNA, Molecular Carcinogenesis, vol.28, issue.2, pp.63-74, 2002.
DOI : 10.1038/sj.onc.1205233

M. Kroon, Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways, J Cell Sci, vol.114, issue.4, pp.825-858, 2001.

C. Tselepis, Desmosomal adhesion inhibits invasive behavior, Proceedings of the National Academy of Sciences, vol.57, issue.5, pp.8064-8073, 1998.
DOI : 10.1073/pnas.92.14.6384

V. Tanos, Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.85, issue.1, pp.7-11, 1999.
DOI : 10.1016/S0301-2115(98)00275-9

I. Matouk, Oncofetal H19 RNA promotes tumor metastasis, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1843, issue.7, pp.1414-1440, 2014.
DOI : 10.1016/j.bbamcr.2014.03.023

D. Marsh, J. Shah, and A. Cole, Histones and Their Modifications in Ovarian Cancer ???????? Drivers of Disease and Therapeutic Targets, Frontiers in Oncology, vol.124, issue.Suppl 2, p.144, 2014.
DOI : 10.1172/JCI69737

C. Lee, Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical and Endometrial Cancer, Cancer Research and Treatment, vol.35, issue.4, pp.314-336, 2003.
DOI : 10.4143/crt.2003.35.4.314

K. Schuster-gossler, The mouseGtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA, Developmental Dynamics, vol.181, issue.2, pp.214-242, 1998.
DOI : 10.1084/jem.181.4.1459

N. Bartonicek, J. Maag, and M. Dinger, Long noncoding RNAs in cancer: mechanisms of action and technological advancements, Molecular Cancer, vol.12, issue.Database issue, p.1, 2016.
DOI : 10.1038/nmeth.3433

L. Benetatos, G. Vartholomatos, and E. Hatzimichael, MEG3 imprinted gene contribution in tumorigenesis, International Journal of Cancer, vol.105, issue.4, pp.773-782, 2011.
DOI : 10.1073/pnas.0801615105

X. Zhang, Y. Zhou, and A. Klibanski, Isolation and characterization of novel pituitary tumor related genes: A cDNA representational difference approach, Molecular and Cellular Endocrinology, vol.326, issue.1-2, pp.40-47, 2010.
DOI : 10.1016/j.mce.2010.02.040

J. Zhang, Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21, Cancer Biology & Therapy, vol.17, issue.1, pp.104-117, 2016.
DOI : 10.1074/jbc.M707224200

S. Huang, The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis, Diagnostic Pathology, vol.8, issue.1, p.1, 2016.
DOI : 10.1002/jso.23888
URL : https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/s13000-016-0499-x

L. Wu, L. Zhang, W. Zhang, and L. , Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis, Medical Science Monitor, vol.22, p.875, 2016.
DOI : 10.12659/MSM.897754
URL : http://europepmc.org/articles/pmc4801156?pdf=render

A. Congrains, ANRIL: Molecular Mechanisms and Implications in Human Health, International Journal of Molecular Sciences, vol.4, issue.1, pp.1278-92, 2013.
DOI : 10.1161/CIRCULATIONAHA.111.06488
URL : http://www.mdpi.com/1422-0067/14/1/1278/pdf

M. Meryet-figuière, An overview of long non-coding RNAs in ovarian cancers, Oncotarget, vol.7, issue.28, pp.44719-44753, 2016.
DOI : 10.18632/oncotarget.8089

J. Qiu, The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer, Oncotarget, vol.7, issue.22, p.32478, 2016.
DOI : 10.18632/oncotarget.8744
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=8744&path%5B%5D=26308

J. Qiu, The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer, Oncotarget, vol.7, issue.22, pp.32478-92, 2016.
DOI : 10.18632/oncotarget.8744
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=8744&path%5B%5D=26308

M. Naemura, Long noncoding RNA ANRIL regulates proliferation of non-small cell lung cancer and cervical cancer cells, Anticancer Res, vol.35, issue.10, pp.5377-82, 2015.

R. Akrami, Comprehensive Analysis of Long Non-Coding RNAs in Ovarian Cancer Reveals Global Patterns and Targeted DNA Amplification, PLoS ONE, vol.128, issue.11, p.80306, 2013.
DOI : 10.1371/journal.pone.0080306.s001

M. Smolle, Long Non-Coding RNAs in Endometrial Carcinoma, International Journal of Molecular Sciences, vol.274, issue.11, pp.26463-72, 2015.
DOI : 10.1158/0008-5472.CAN-12-2850

M. Xue, W. Chen, and X. Li, Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer, Journal of Cancer Research and Clinical Oncology, vol.48, issue.3, pp.1407-1426, 2016.
DOI : 10.1530/JME-12-0008

X. Wang, Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder Carcinoma, Clinical Cancer Research, vol.12, issue.16, pp.4851-4859, 2006.
DOI : 10.1158/1078-0432.CCR-06-0134
URL : http://clincancerres.aacrjournals.org/content/clincanres/12/16/4851.full.pdf

W. Tsang, Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR, RNA, vol.13, issue.6, pp.890-898, 2007.
DOI : 10.1261/rna.359007

L. Zhang, UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy, Cancer Chemotherapy and Pharmacology, vol.6, issue.3, pp.629-663, 2016.
DOI : 10.18632/oncotarget.4361

B. Wang, Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer, Cancer Biotherapy and Radiopharmaceuticals, vol.32, issue.3, pp.101-111, 2017.
DOI : 10.1089/cbr.2016.2156

R. Lanz, Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo, Molecular and Cellular Biology, vol.23, issue.20, pp.7163-76, 2003.
DOI : 10.1128/MCB.23.20.7163-7176.2003
URL : http://mcb.asm.org/content/23/20/7163.full.pdf

X. Zhong, X. Hu, and L. Zhang, Oncogenic long noncoding RNA FAL1 in human cancer, Molecular & Cellular Oncology, vol.2, issue.2, p.977154, 2015.
DOI : 10.1016/j.molcel.2010.03.021
URL : http://europepmc.org/articles/pmc4905162?pdf=render

A. Sahu, U. Singhal, and A. Chinnaiyan, Long noncoding RNAs in cancer: from function to translation. Trends in cancer, pp.93-109, 2015.
DOI : 10.1016/j.trecan.2015.08.010
URL : https://manuscript.elsevier.com/S2405803315000217/pdf/S2405803315000217.pdf

Z. Cheng, A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer, Oncotarget, vol.6, issue.28, p.25381, 2015.
DOI : 10.18632/oncotarget.4541
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=4541&path%5B%5D=12387

Y. Gao, LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b, Human Molecular Genetics, vol.43, issue.3, pp.841-52, 2015.
DOI : 10.1038/onc.2012.239
URL : https://academic.oup.com/hmg/article-pdf/24/3/841/17263628/ddu502.pdf

J. Silva, LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation, RNA Biology, vol.8, issue.3, pp.496-505, 2011.
DOI : 10.4161/rna.8.3.14800
URL : http://www.tandfonline.com/doi/pdf/10.4161/rna.8.3.14800?needAccess=true

Y. Guan, Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer, Clinical Cancer Research, vol.13, issue.19, pp.5745-55, 2007.
DOI : 10.1158/1078-0432.CCR-06-2882

Y. Tseng, PVT1 dependence in cancer with MYC copy-number increase, Nature, vol.512, issue.7512, pp.82-88, 2014.
DOI : 10.1038/ng.2641
URL : http://europepmc.org/articles/pmc4767149?pdf=render

E. Richards, A functional variant in <i>HOXA11-AS</i>, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer, Oncotarget, vol.6, issue.33, p.34745, 2015.
DOI : 10.18632/oncotarget.5784

D. Wu, Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin, Oncology Letters, vol.11, issue.2, pp.1189-94, 2016.
DOI : 10.3892/ol.2015.3983

M. Zhao, Long Non-Coding RNAs Involved in Gynecological Cancer, International Journal of Gynecological Cancer, vol.24, issue.7, pp.1140-1145, 2014.
DOI : 10.1097/IGC.0000000000000212

N. Sun, Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer, PLoS ONE, vol.7, issue.2, p.100340, 2014.
DOI : 10.1371/journal.pone.0100340.s006
URL : https://doi.org/10.1371/journal.pone.0100340

C. Schneider, R. King, and L. Philipson, Genes specifically expressed at growth arrest of mammalian cells, Cell, vol.54, issue.6, pp.787-93, 1988.
DOI : 10.1016/S0092-8674(88)91065-3

M. Pickard and G. Williams, Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA, Genes, vol.10, issue.3, pp.484-99, 2015.
DOI : 10.3389/fgene.2015.00168
URL : http://www.mdpi.com/2073-4425/6/3/484/pdf

M. Pickard and G. Williams, The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells, Oncotarget, vol.7, issue.9, p.10104, 2016.
DOI : 10.18632/oncotarget.7173

S. Cao, Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer, Int J Clin Exp Pathol, vol.7, issue.10, pp.6776-83, 2014.

M. Yang, Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA, Tumor Biology, vol.491, issue.7424, pp.7615-7637, 2015.
DOI : 10.1038/nature11508

S. Jiang, H. Wang, and Y. J. , Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer, Int J Clin Exp Pathol, vol.8, issue.1, pp.806-817, 2015.

A. Fader and P. Rose, Role of Surgery in Ovarian Carcinoma, Journal of Clinical Oncology, vol.25, issue.20, pp.2873-83, 2007.
DOI : 10.1200/JCO.2007.11.0932

A. Jemal, Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.82, issue.19 suppl, pp.69-90, 2011.
DOI : 10.1097/00002030-199912240-00012

R. Coleman, Latest research and treatment of advanced-stage epithelial ovarian cancer, Nature Reviews Clinical Oncology, vol.69, issue.4, pp.211-235, 2013.
DOI : 10.1158/0008-5472.CAN-08-3913
URL : http://europepmc.org/articles/pmc3786558?pdf=render

S. Liu, MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells, Tumor Biology, vol.30, issue.1, pp.633-673, 2016.
DOI : 10.1038/onc.2011.203

H. Lu, Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145, Tumor Biology, vol.495, issue.2, pp.1683-91, 2016.
DOI : 10.1038/nature11993

L. Liao, Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer, Gynecologic Oncology, vol.133, issue.3, pp.616-639, 2014.
DOI : 10.1016/j.ygyno.2014.03.555

Y. Wu, Long noncoding RNA HOTAIR involvement in cancer, Tumor Biology, vol.7, issue.12, pp.9531-9539, 2014.
DOI : 10.1371/journal.pone.0052984

I. Ariel, Genomic Imprinting and the Endometrial Cycle, Diagnostic Molecular Pathology, vol.6, issue.1, pp.17-25, 1997.
DOI : 10.1097/00019606-199702000-00004

V. Tanos, H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium, International Journal of Gynecological Cancer, vol.14, issue.3, pp.521-526, 2004.
DOI : 10.1111/j.1048-891x.2004.014314.x

S. Ghazal, H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis, EMBO Molecular Medicine, vol.7, issue.8, pp.996-1003, 2015.
DOI : 10.15252/emmm.201505245

S. Douc-rasy, High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19, Oncogene, vol.12, issue.2, pp.423-453, 1996.

L. Yan, Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation, Oncogene, vol.11, issue.23, pp.3076-84, 2015.
DOI : 10.4161/cc.20893

R. Qin, Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis, Neoplasma, vol.60, issue.05, pp.486-92, 2012.
DOI : 10.4149/neo_2013_063

X. Chen, L. Liu, and W. Zhu, Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients, Int J Clin Exp Pathol, vol.8, issue.10, p.13261, 2015.

J. Qiu, Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer, International Journal of Oncology, vol.46, issue.6, pp.2497-505, 2015.
DOI : 10.3892/ijo.2015.2943

A. Teschendorff, HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer, Genome Medicine, vol.333, issue.1, p.1, 2015.
DOI : 10.1016/j.yexcr.2015.03.005

M. Zhou, Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network, Molecular BioSystems, vol.26, issue.suppl. 7, pp.760-769, 2015.
DOI : 10.1093/bioinformatics/btq108

A. Rodriguez, Identification of Mammalian microRNA Host Genes and Transcription Units, Genome Research, vol.14, issue.10a, pp.1902-1912, 2004.
DOI : 10.1101/gr.2722704

R. Cao and Y. Zhang, The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3, Current Opinion in Genetics & Development, vol.14, issue.2, pp.155-64, 2004.
DOI : 10.1016/j.gde.2004.02.001

, ? We accept pre-submission inquiries ? Our selector tool helps you to find the most relevant journal ? We provide round the clock customer support ? Convenient online submission ? Thorough peer review ? Inclusion in PubMed and all major indexing services ? Maximum visibility for your research Submit your manuscript at www.biomedcentral, com/submit Submit your next manuscript to BioMed Central and we will help you at every step